<tr id='6h1k7'><strong id='6h1k7'></strong><small id='6h1k7'></small><button id='6h1k7'></button><li id='6h1k7'><noscript id='6h1k7'><big id='6h1k7'></big><dt id='6h1k7'></dt></noscript></li></tr><ol id='6h1k7'><option id='6h1k7'><table id='6h1k7'><blockquote id='6h1k7'><tbody id='6h1k7'></tbody></blockquote></table></option></ol><u id='6h1k7'></u><kbd id='6h1k7'><kbd id='6h1k7'></kbd></kbd>
生物醫藥高科技公(gong)司諾誠健華宣布，公(gong)司旗(qi)下布魯(lu)頓酪氨酸(suan)激酶(BTK)抑制(zhi)劑奧布替尼的(de)10項研究(jiu)入選第64屆美(mei)(mei)國血液(ye)學協會(hui)(ASH)年(nian)會(hui)。本(ben)次(ci)ASH年(nian)會(hui)將于2022年(nian)12月10-13日在美(mei)(mei)國新(xin)奧爾(er)良以(yi)線(xian)上及線(xian)下形式舉(ju)辦。(醫藥健聞)
